Uptake and outcomes of small intestinal and urinary tract cancer surveillance in Lynch syndrome

Table 1 Small intestinal cancer and urinary tract cancer surveillance outcomes in Lynch syndrome

	n = 317
Individuals who underwent SIC surveillance	86 (27%)
SIC surveillance exams completed per individual, median (IQR)	1 (1-1)
Total completed SIC surveillance exams	105
VCE	58 (55%)
SBFT	47 (45%)
Abnormal SIC surveillance exams leading to further work-up	5 (5%)
VCE	5 (100%)
SBFT	0 (0%)
Abnormal SIC surveillance exams leading to a SIC diagnosis	0 (0%)
Individuals who underwent UTC surveillance	99 (31%)
UTC surveillance exams completed per individual, median (IQR)	2 (1-3)
Total completed UTC surveillance exams	303
Urinalysis	197 (65%)
Urine cytology	106 (35%)
Abnormal UTC surveillance exams leading to further work-up	19 (6%)
Urinalysis	9 (47%)
Urine Cytology	10 (53%)
Abnormal UTC surveillance exams leading to a UTC diagnosis	1 (5%)

SIC: Small intestinal cancer; UTC: Urinary tract cancer; VCE: Video capsule endoscopy; SBFT: Small bowel follow through.